FDA inspection
Sun Pharmaceutical Medicare Limited: FDA inspection ending Feb 27, 2024
FDA inspection 1231121 · No Action Indicated (NAI) · Halol
Key facts
| Inspection ID | 1231121 |
|---|---|
| Firm | Sun Pharmaceutical Medicare Limited |
| FEI number | 3002957541 |
| Address | 22 - 24 Village Ujeti, Post Baska; Survey No |
| City | Halol |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Feb 27, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data